386 studies found for:    biogen | biogen
Show Display Options
Rank Status Study
21 Recruiting Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS)
Condition: Multiple Sclerosis
Intervention:
22 Recruiting Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke
Condition: Acute Ischemic Stroke
Interventions: Drug: natalizumab;   Drug: Placebo
23 Recruiting Clinical Disease Activity With Long Term Natalizumab Treatment
Condition: Relapsing-Remitting Multiple Sclerosis (RRMS)
Intervention: Drug: natalizumab
24 Recruiting Single and Multiple Dose Study of BIIB067 (Isis-SOD1Rx) in Adults With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: BIIB067 (Isis-SOD1Rx);   Other: Placebo
25 Recruiting Methodology Study of Novel Outcome Measures to Assess Progression of ALS
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention:
26 Recruiting Plegridy Satisfaction Study in Participants
Condition: Relapsing-Remitting Multiple Sclerosis (RRMS)
Intervention: Drug: peginterferon beta-1a
27 Recruiting Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: dimethyl fumarate
28 Recruiting Tecfidera Lymphocyte Chart Review
Condition: Multiple Sclerosis
Intervention: Drug: dimethyl fumarate
29 Recruiting Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) Scale
Condition: Severe Hemophilia A
Intervention: Biological: rFVIIIFc
30 Recruiting 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Aducanumab (BIIB037);   Drug: Placebo
31 Recruiting 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Aducanumab (BIIB037);   Drug: Placebo
32 Recruiting Tecfidera and the Gut Microbiota
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: dimethyl fumarate;   Drug: injectable MS DMT
33 Recruiting Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: BIIB054;   Drug: Placebo
34 Recruiting Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell Disease
Conditions: Healthy;   Sickle Cell Disease
Intervention:
35 Recruiting Sjögren's Biomarker Study
Conditions: Healthy;   Sjögren's Syndrome
Intervention:
36 Recruiting Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera
Condition: Multiple Sclerosis
Interventions: Drug: dimethyl fumarate;   Drug: montelukast;   Drug: Placebo
37 Recruiting Observational Study to Assess the Correlation of EDSS With Quality of Life in MS Participants Treated With Natalizumab
Condition: Multiple Sclerosis
Intervention: Drug: natalizumab
38 Recruiting Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)
Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: dimethyl fumarate;   Drug: Interferon β-1a
39 Recruiting An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Untreated Males With Severe Hemophilia A
Condition: Hemophilia A
Intervention: Biological: rFVIIIFc
40 Recruiting Study to Determine the Safety and Efficacy of rFIXFc in Untreated Males With Severe Hemophilia B
Condition: Hemophilia B
Intervention: Biological: rFIXFc

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years